Category: Hologic Inc.
Here's a look at some of the top Wall Street stories for medical device companies this week: Hologic's CEO praises its activist investor; Lantheus spikes IPO plans; Ex-CEO Pignatelli backs down, but not out, in spat with Biolase; Symmetry Medical sells its OEM biz to Tecomet for $450M; Valeant's hostile takeover hopes fade as Allergan war continues
Hologic CEO Steven MacMillan says activist investor Carl Icahn, who pushed his way into the board room last year, is "clearly not a micro-manager."
Hologic (NSDQ:HOLX) CEO Steven MacMillan offered a glowing review to major stakeholder Carl Icahn, saying that activist investor is "not into our shorts at all."
Hologic swings to fiscal 3rd-quarter profits despite flat sales growth and raises its sales and earnings forecasts for the rest of fiscal 2014.
Hologic (NSDQ:HOLX) swung to 3rd-quarter black during the 3 months ended June 28, despite flat sales growth of just 1%, and boosted its outlook for the rest of its fiscal year.
Here's a look at some of the top funding stories for medical device companies this week: Intersect ENT registers $80M IPO for sinus implants; Mitralign raises another $8M; Device makers tally $67M in Pentagon deals; EndoShape raises $6.8M for vascular plugs and coils; EMBA Medical's still working on its $3M funding round
Hologic, Welch Allyn, InVivo, Digirad and ICAD claim nearly $67 million in medtech contracts with the Dept. of Defense.
The Defense Dept. handed out some $66.7 million in supply contracts to 5 medical device makers, covering Pap test kits, radiology and patient monitoring systems.
Here's a look at some of the top personnel stories for medical device companies this week: Stryker must face class action employment claims; Staar Surgical hires consumer marketing expert to move Visian lenses; Hologic taps J&J vet McMahon as new CFO; Echo Therapeutics battles 'dissident' stockholder and pool-industry board nominee.
Hologic names the former finance veep for Johnson & Johnson's Ortho-Clinical Diagnostics business as its new CFO.